Administration for anti-TIGIT antibody and anti-CD 20 antibody or anti-CD 38 antibody… Application CN-113710706-A China 26 Nov 2021
DOSING FOR TREATMENT WITH ANTI-TIGIT AND ANTI-CD20 OR ANTI-CD38 ANTIBODIES Application WO-2020176748-A1 World Intellectual Property Organisation (WIPO) 03 Sep 2020